Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

35 citing papers in PubMed.

1. Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine.Frontiers in immunology · 2021
   Trial
2. Severity of respiratory illness among Covid-19-vaccinated and non-vaccinated admitted patients-An observational study from a teaching hospital of Tripura.Journal of family medicine and primary care · 2024
   Article
3. Clinical characterization, molecular and genomic sequencing analysis of SARS-Cov-2 during second wave at Raigarh, Chhattisgarh, India.Bioinformation · 2024
   Article
4. Acceptance of Annual Booster Doses of COVID-19 Vaccines Among Indian Healthcare Professionals: A Pan-India Cross-Sectional Survey.Cureus · 2023
   Article
5. Anti-SARS-CoV-2 spike immunoglobulin G and immunoglobulin M titers decline as interval from the second inactivated vaccine dose to the onset of illness is prolonged in breakthrough infection patients.The clinical respiratory journal · 2023
   Article
6. Death Reporting in Breakthrough and Unvaccinated SARS-CoV-2 Infection Cases.Disaster medicine and public health preparedness · 2023
   Article
7. COVID-19 Breakthrough Infection Among Vaccinated Population in the United Arab Emirates.Journal of epidemiology and global health · 2023
   Article
8. Epidemiological characteristics and quarantine assessment of imported international COVID-19 cases, March to December 2020, Chengdu, China.Scientific reports · 2022
   Article
9. SARS-CoV-2 Variants of Concern and Variations within Their Genome Architecture: Does Nucleotide Distribution and Mutation Rate Alter the Functionality and Evolution of the Virus?Viruses · 2022
   Article
10. Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study.BMC infectious diseases · 2022
    Article
11. Genomics of postvaccination SARS-CoV-2 infections during the Delta dominated second wave of COVID-19 pandemic, from Mumbai Metropolitan Region (MMR), India.Journal of medical virology · 2022
    Article
12. Incidence and severity of COVID-19 infection post-vaccination: a survey among Indian doctors.Infection · 2022
    Article
13. Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021.The Journal of infection · 2022
    Article
14. Zika, Nipah and Kala-azar: Emerging lethal infectious diseases amid COVID-19 as an escalating public health threat in South India.Annals of medicine and surgery (2012) · 2022
    Article
15. Transmission of B.1.617.2 Delta variant between vaccinated healthcare workers.Scientific reports · 2022
    Article
16. Characteristics of COVID-19 Breakthrough Infections among Vaccinated Individuals and Associated Risk Factors: A Systematic Review.Tropical medicine and infectious disease · 2022
    Review
17. Clinical and Laboratory Features in the Israeli Population with COVID-19 Infection after Pfizer-BioNTech mRNA Booster Vaccination.Vaccines · 2022
    Article
18. Vaccine effectiveness to protect against moderate or severe disease in COVID cases: A prospective cohort study.Medical journal, Armed Forces India · 2022
    Article
19. Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India.Journal of medical virology · 2022
    Article
20. SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker.The Journal of infection · 2022
    Article

Corrections and comments

• Commented on by
  SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker.2022
• Comment on
  Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers.2021

Authors and funding

26 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as